Font Size:
a
A
A
Keyword [ST segment elevation]
Result: 161 - 180 | Page: 9 of 10
161.
The Comparative Study Of Introcoronary Tirofiban Preoperative Versus Intranperative In Non-ST-segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Treatment
162.
The Clinical Value Of Cystatin C In Non ST Segment Elevation Acute Coronary Syndrome
163.
An Analysis Of The Correlation Between FQRS Detection Rate In The Body Surface Electrocardiogram And The Ischemia Range And Degree Of Acute ST Segment Elevation Myocardial Infarction
164.
Caridoprotective Effect Of Loading Dose Atorvastatin Pretreatment In Patients With Acute ST-segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
165.
A Follow-up Analysis Of Prognosis And Relational Factors In Elderly Patients With Non-st-segment Elevation Myocardial Infarction
166.
Research Of The Relations Hip Between ECG And The Result Of Coronary Angiography In Non-ST-Segment Elevation Myocardial Infarction
167.
The Association Of Uric Acid With Coronary Flow And Prognosis In ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
168.
Factors Related To Prehospital And In-hospital Time Delay Of Emergency Percutaneous Interventional Therapy In Acute ST-segment Elevation Myocardial Infarction
169.
The Clinical Efficacy Of Thrombus Aspiration In ST-elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
170.
The Research Into The Time Distribution Of In-hospital Treatment Delay And The Influential Factors In Patients With Acute St-segment Elevation Myocardial Infarction
171.
Myocardial Protect Of Lipoic Acid In Patients With Acute St Segment Elevation Myocardial Infarction After Emergency Interventional Therapy:a Randomized Trial
172.
The Influence Of Plasma N-terminal Brain Nartiuretic Peptide Precursor On The Prognosisof Acute Myocardial Infaction After Intravenous Thrombolysis
173.
Relationship Between Blood C-reactive Protein,Cystatin C, Apolipoprotein A, And Lipoprotein A And Grace Risk Score In Patients With Non-st Segment Elevation Acute Coronary Syndrome
174.
Predictors Of Myocardial No-reflow Following Percutaneous Coronary Intervention:a Meta-analysis
175.
Clinical Study On The Relationships Between GRACE Risk Score Or Concentration Of Plasma D-Dimer And The Severity Of Coronary Artery Pathological Changes In Patients With Acute ST-segment Elevation Myocardial Infraction
176.
Research On The Efficacy And Safety Of Shuxuetong Injection On The Clopidogrel Non-responders Or Low Responders With NSTE-ACS
177.
Drug-eluting Stents And Bare Metal Stents In Acute ST Segment Elevation Myocardial Infarction, The Application Of Comparative Study
178.
Effect Of Mean Platelet Volume (MPV)/Platelet Count(PLT)(MPV/PLT) And White Blood Cell Count (WBC) On The Hospital Mortality In ST Segment Elevation Myocardial Infarction (STEMI) Patients With Advanced Revascularization And Post PCI Operation
179.
The Relationship Between The GRACE Score And Interventional Treatment Of Non-ST Segment Elevation Acute Coronary Syndrome
180.
The Value Of ST Segment Changes Of AVR Lead For Predicting The Infarction Related Artery And Evaluating The Short-term Prognosis In ST-segment Elevation Myocardial Infarction
<<First
<Prev
Next>
Last>>
Jump to